TABLE 8.
PROs Stratified by Surgical Plan
| Questionnaires | Surgical plan | AE status | Baseline | 3 months | 12 months |
|---|---|---|---|---|---|
| EQ-5D | Intralesional | No AE | 0.55 (0.21) | 0.72 (0.10) | 0.74 (0.09) |
| Mean (SD) | Any AE | 0.57 (0.23) | 0.66 (0.18) | 0.67 (0.17) | |
| En bloc | No AE | 0.64 (0.19) | 0.64 (0.14) | 0.73 (0.13) | |
| Any AE | 0.62 (0.18) | 0.60 (0.16) | 0.66 (0.15) | ||
| SF36 physical | Intralesional | No AE | 37.53 (11.10) | 41.90 (8.98) | 45.12 (11.33) |
| Mean (SD) | Any AE | 33.14 (11.29) | 38.04 (12.55) | 38.39 (10.07) | |
| En bloc | No AE | 41.95 (11.38) | 38.48 (9.89) | 44.58 (9.87) | |
| Any AE | 39.42 (12.71) | 34.40 (9.07) | 39.60 (12.51) | ||
| SF36 Mental | Intralesional | No AE | 45,48 (13.02) | 54.11 (8.53) | 56.25 (9.84) |
| Mean (SD) | Any AE | 40.54 (13.75) | 48.65 (10.59) | 50.25 (8.66) | |
| En bloc | No AE | 45.61 (13.10) | 47.56 (12.23) | 48.67 (10.71) | |
| Any AE | 46.59 (12.32) | 47.02 (12.75) | 50.36 (13.14) | ||
| SOSGOQ | Intralesional | No AE | 0.69 (0.18) | 0.78 (0.13) | 0.88 (0.10) |
| Mean (SD) | Any AE | 0.60 (0.25) | 0.71 (0.17) | 0.68 (0.22) | |
| En bloc | No AE | 0.74 (0.16) | 0.69 (0.17) | 0.77 (0.13) | |
| Any AE | 0.70 (0.17) | 0.65 (0.19) | 0.75 (0.17) |
AE, adverse event; EQ-5D, EuroQol 5D; SF-36, Short-Form 36; SOSGOQ, Spine Oncology Study Group Outcomes Questionnaire.
Results with a P-value <.05 are highlighted in bold.